Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. [30] [27] [31] [32] It is specifically used for cancer …

Mar 26, 2024 · Trastuzumab is used to treat certain types of breast cancer or stomach cancer, sometimes in combination with other cancer medicines. trastuzumab is sometimes used when …

3 days ago · Fam-trastuzumab deruxtecan-nxki (T-DXd) is approved for HER2-low or HER2-ultralow metastatic breast cancer post-endocrine therapy. DESTINY-Breast06 trial showed T …

2 days ago · Trastuzumab deruxtecan demonstrated a higher objective response rate of 62.6% compared to 34.4% with chemotherapy. Approximately 85%-90% of HR-positive, HER2 …

4 days ago · AstraZeneca and Daiichi Sankyo’s ENHERTU ® (fam-trastuzumab deruxtecan-nxki) has been approved in the US for the treatment of adult patients with unresectable or …

3 days ago · AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone …

Trastuzumab works by binding to HER2, a protein found in high levels on some cancer cells and causes them to grow. Trastuzumab blocks the activity of HER2 and triggers a type of immune …

Jun 22, 2024 · Trastuzumab is an FDA-approved antineoplastic biologic that targets HER2-positive breast and gastric cancer.

3 days ago · The FDA has approved fam-trastuzumab deruxtecan, marketed under the brand name Enhertu, as a new treatment for certain types of advanced breast cancer that have …

3 days ago · In DESTINY-Breast06, patients treated with trastuzumab deruxtecan had a median progression-free survival (PFS) of 13.2 compared with those who were randomized to …